Yingqian Zhang

Dr. Yingqian Zhang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YZYinbing Zhang
Yinbing Zhang
CTCheng Tang
Cheng Tang
YHYao He
Yao He
YZYingqian Zhang
Yingqian Zhang
QLQinxi Li
Qinxi Li
ZZZhihui Zhong
Zhihui Zhong

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
LWLixiu Wang
Lixiu Wang
YBYayan Bi
Yayan Bi
MCMuhua Cao
Muhua Cao
RMRuishuang Ma
Ruishuang Ma
XWXiaoming Wu
Xiaoming Wu
JSJialan Shi
Jialan Shi

9 February 2022 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
YZYingqian Zhang
Yingqian Zhang
BZBangcheng Zhao
Bangcheng Zhao
QLQi Lai
Qi Lai
QLQinxi Li
Qinxi Li
XTXun Tang
Xun Tang
ZZZhihui Zhong
Zhihui Zhong
Blood-brain barrier (BBB) disruption is a pivotal pathophysiological process in ischemic stroke. Although temporal changes in BBB permeability during the acute phase have been widely studied, little is known about the chronic phase of cerebrovascular changes that may have a large impact on the long-term outcome. Therefore, this study was aimed to measure cerebral vascular abnormalities using CT perfusion in nine rhesus monkeys subjected to transient middle cerebral artery occlusion (tMCAO) for ≥1 year (MCAO-1Y+). The level of cerebral perfusion demonstrated by mean transit time was significantly higher in the ipsilateral caudate nucleus, white matter, thalamus, hippocampus, and contralateral thalamus in MCAO-1Y+ compared with the other nine age-matched control monkeys. The increase in BBB permeability measured through the permeability surface was found in the same ten regions of interest ipsilaterally and contralaterally. We also found decreased levels of Aβ 42/40 ratio in the cerebrospinal fluid (CSF), suggesting a potential link between post-MCAO cognitive decline and Aβ metabolism. Overall, we demonstrated significant cerebral hypoperfusion, BBB disruption, and CSF Aβ decrease during the rehabilitation stage of ischemic stroke in a non-human primate model. Future studies are needed to elucidate the cause-effect relationship between cerebrovascular disruptions and long-term neurological deficits.

14 May 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QLQinxi Li
Qinxi Li
BZBangcheng Zhao
Bangcheng Zhao
WLWanxin Li
Wanxin Li
YHYao He
Yao He
XTXun Tang
Xun Tang
YZYingqian Zhang
Yingqian Zhang

16 February 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
Aristo VojdaniAristo Vojdani
Aristo Vojdani
AAAbbas F. Almulla
Abbas F. Almulla
EVElroy Vojdani
Elroy Vojdani
JLJing Li
Jing Li
YZYingqian Zhang
Yingqian Zhang
MMMichael Maes
Michael Maes
The pathogenesis of relapsing-remitting multiple sclerosis (RRMS) is linked to autoimmune attacks against myelin proteins, and reactivation of Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6). However, the connection between viral reactivation and autoimmune biomarkers has remained unclear. To investigate immunoglobulin (Ig)G/IgA/IgM responses targeting myelin-related proteins in association with EBV and HHV-6 replication markers in RRMS. We recruited 55 patients with RRMS and 63 healthy controls and assessed IgG/IgA/IgM responses against seven myelin-related components, as well as EBV nuclear antigen 1 (EBNA-1) and deoxyuridine-triphosphate nucleotidohydrolase (dUTPases). Disability was evaluated using the Expanded Disability Status Scale (EDSS) and disease progression using the Multiple Sclerosis Severity Score (MSSS). IgG/IgA/IgM levels targeting seven myelin-related proteins were significantly higher in RRMS than in controls. IgG against myelin basic protein (MBP) (IgG-MBP), IgM-myelin-associated glycoprotein (IgM-MAG)-37-60, IgA-MBP, and IgA-myelin-oligodendrocyte-glycoprotein (IgA-MOG-31-55) distinguished RRMS from controls with a predictive accuracy of 96.6 % (sensitivity = 95.7 %, specificity = 95.2 %) and an area under the ROC curve of 0.991. A large part of the variance in the EDSS (around 75 %) and MSSS score (62.8 %) was explained by IgG-MBP, IgM-MBP, IgA-MOG-31-55, and IgM-MAG. Part of the variance (47.4 %) in the IgG/IgA/IgM responses to myelin-related proteins was explained by immune responses to EBNA and dUTPases of EBV and HHV-6. Autoimmune reactivities targeting myelin-related proteins are valuable biomarkers of RRMS and the severity and progression of RRMS. Reactivation of EBV and HHV-6 may trigger or maintain these autoimmune responses thereby impacting disease progression.

24 February 2026 in Acta Neuropsychiatrica
Verified
Journal Article
Open access
PDF file
MMMichael Maes
Michael Maes
MNMengqi Niu
Mengqi Niu
AMAnnabel Maes
Annabel Maes
YLYiping Luo
Yiping Luo
CYChenkai Yangyang
Chenkai Yangyang
YZYingqian Zhang
Yingqian Zhang
Background: Major depressive disorder (MDD) is a neuro-immune, oxidative, and nitrosative stress (NIMETOX) disorder, in which peripheral immune-redox pathways intersect with metabolic networks leading to neurotoxicity within the limbic-prefrontal affective circuits. Comprehensive metabolomics analysis in well-phenotyped patients is vital to elucidate their metabolic profile. Objectives: To identify metabolic abnormalities that differentiate in patients with severe MDD from healthy controls(HCs) through high-resolution, untargeted metabolomics. Methods: Serum samples from 125 MDD inpatients and 40 HCs were analyzed utilizing liquid chromatography(LC) and mass spectrometry(MS). A meticulously regulated multistage machine-learning pipeline with leakage-prevention protocols was employed to analyze differences between MDD and controls and to predict phenome scores. Results: Feature selection showed that 16 metabolites and 6 functional modules reliably distinguished MDD. The functional profile of the metabolites indicates a convergence of lipotoxicity, phospholipid(PL) remodeling, disruptions in fatty acid(FA) metabolism, mitochondrial redox imbalance, ether-lipid metabolism, and antioxidant depletion. This MDD metabotype was not affected by metabolic syndrome(MetS). A substantial portion of the variance in overall depression severity (72.5%), physiosomatic symptoms (55.8%), and suicidal ideation(SI) (23.6%) was accounted for by increased lipotoxicity, PL remodeling, and FA storage/signaling. The recurrence of illness (27.7%) was associated with a self-reinforcing lipid-redox-inflammatory module that maintains cellular stress. Discussion: The MDD metabotype represents a cohesive metabolic network that is associated with the NIMETOX pathogenesis of MDD. Metabolomics provides a comprehensive foundation for subtyping and precision psychiatry. Lipoxygenase-15, lipotoxicity, phospholipase A 2 , and lipid-redox intersections might be important drug targets to treat MDD.